Literature DB >> 23245646

Conducting radiogenomic research--do not forget careful consideration of the clinical data.

Christian Nicolaj Andreassen1, Gillian C Barnett, Johannes A Langendijk, Jan Alsner, Dirk De Ruysscher, Mechtild Krause, Søren M Bentzen, Joanne S Haviland, Clare Griffin, Philip Poortmans, John R Yarnold.   

Abstract

The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 23245646     DOI： 10.1016/j.radonc.2012.11.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  14 in total

Review 1.  Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.

Authors:  Sarah L Kerns; Harry Ostrer; Barry S Rosenstein
Journal:  Cancer Discov       Date:  2014-01-17       Impact factor: 39.397

Review 2.  Radiogenomics and radiotherapy response modeling.

Authors:  Issam El Naqa; Sarah L Kerns; James Coates; Yi Luo; Corey Speers; Catharine M L West; Barry S Rosenstein; Randall K Ten Haken
Journal:  Phys Med Biol       Date:  2017-08-01       Impact factor: 3.609

Review 3.  Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity.

Authors:  Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

Review 4.  The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Authors:  Sarah L Kerns; Suman Kundu; Jung Hun Oh; Sandeep K Singhal; Michelle Janelsins; Lois B Travis; Joseph O Deasy; A Cecile J E Janssens; Harry Ostrer; Matthew Parliament; Nawaid Usmani; Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

5.  Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Authors:  Christian Nicolaj Andreassen; Barry S Rosenstein; Sarah L Kerns; Harry Ostrer; Dirk De Ruysscher; Jamie A Cesaretti; Gillian C Barnett; Alison M Dunning; Leila Dorling; Catharine M L West; Neil G Burnet; Rebecca Elliott; Charlotte Coles; Emma Hall; Laura Fachal; Ana Vega; Antonio Gómez-Caamaño; Christopher J Talbot; R Paul Symonds; Kim De Ruyck; Hubert Thierens; Piet Ost; Jenny Chang-Claude; Petra Seibold; Odilia Popanda; Marie Overgaard; David Dearnaley; Matthew R Sydes; David Azria; Christine Anne Koch; Matthew Parliament; Michael Blackshaw; Michael Sia; Maria J Fuentes-Raspall; Teresa Ramon Y Cajal; Agustin Barnadas; Danny Vesprini; Sara Gutiérrez-Enríquez; Meritxell Mollà; Orland Díez; John R Yarnold; Jens Overgaard; Søren M Bentzen; Jan Alsner
Journal:  Radiother Oncol       Date:  2016-07-18       Impact factor: 6.280

6.  Radiogenomics: radiobiology enters the era of big data and team science.

Authors:  Barry S Rosenstein; Catharine M West; Søren M Bentzen; Jan Alsner; Christian Nicolaj Andreassen; David Azria; Gillian C Barnett; Michael Baumann; Neil Burnet; Jenny Chang-Claude; Eric Y Chuang; Charlotte E Coles; Andre Dekker; Kim De Ruyck; Dirk De Ruysscher; Karen Drumea; Alison M Dunning; Douglas Easton; Rosalind Eeles; Laura Fachal; Sara Gutiérrez-Enríquez; Karin Haustermans; Luis Alberto Henríquez-Hernández; Takashi Imai; George D D Jones; Sarah L Kerns; Zhongxing Liao; Kenan Onel; Harry Ostrer; Matthew Parliament; Paul D P Pharoah; Timothy R Rebbeck; Christopher J Talbot; Hubert Thierens; Ana Vega; John S Witte; Philip Wong; Frederic Zenhausern
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-15       Impact factor: 7.038

7.  A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.

Authors:  Laura Fachal; Antonio Gómez-Caamaño; Gillian C Barnett; Paula Peleteiro; Ana M Carballo; Patricia Calvo-Crespo; Sarah L Kerns; Manuel Sánchez-García; Ramón Lobato-Busto; Leila Dorling; Rebecca M Elliott; David P Dearnaley; Matthew R Sydes; Emma Hall; Neil G Burnet; Ángel Carracedo; Barry S Rosenstein; Catharine M L West; Alison M Dunning; Ana Vega
Journal:  Nat Genet       Date:  2014-06-29       Impact factor: 38.330

8.  Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis.

Authors:  Yu-Zhe Song; Fu-Jun Han; Min Liu; Cheng-Cheng Xia; Wei-Yan Shi; Li-Hua Dong
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

9.  The current progress and future prospects of personalized radiogenomic cancer study.

Authors:  Juhn-Cherng Liu; Wu-Chung Shen; Tzu-Ching Shih; Chia-Wen Tsai; Wen-Shin Chang; Der-Yang Cho; Chang-Hai Tsai; Da-Tian Bau
Journal:  Biomedicine (Taipei)       Date:  2015-02-02

10.  Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy.

Authors:  Charlotte B Westbury; Joanne Haviland; Sue Davies; Lone Gothard; Bahja Ahmed Abdi; Mark Sydenham; Jo Bowen; Richard Stratton; Susan C Short; John R Yarnold
Journal:  Radiat Oncol       Date:  2014-04-30       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.